Your browser doesn't support javascript.
loading
A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.
Bricault, Christine A; Kovacs, James M; Nkolola, Joseph P; Yusim, Karina; Giorgi, Elena E; Shields, Jennifer L; Perry, James; Lavine, Christy L; Cheung, Ann; Ellingson-Strouss, Katharine; Rademeyer, Cecelia; Gray, Glenda E; Williamson, Carolyn; Stamatatos, Leonidas; Seaman, Michael S; Korber, Bette T; Chen, Bing; Barouch, Dan H.
Afiliación
  • Bricault CA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Kovacs JM; Division of Molecular Medicine, Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Nkolola JP; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Yusim K; Theoretical Biology and Biophysics, Los Alamos National Laboratory, and the New Mexico Consortium, Los Alamos, New Mexico, USA.
  • Giorgi EE; Theoretical Biology and Biophysics, Los Alamos National Laboratory, and the New Mexico Consortium, Los Alamos, New Mexico, USA.
  • Shields JL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Perry J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Lavine CL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Cheung A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Ellingson-Strouss K; Seattle Biomedical Research Institute, and University of Washington, Department of Global Health, Seattle, Washington, USA.
  • Rademeyer C; Institute of Infectious Diseases and Molecular Medicine, Division of Medical Virology, University of Cape Town, Cape Town, South Africa.
  • Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, and South African Medical Research Council, Cape Town, South Africa.
  • Williamson C; Institute of Infectious Diseases and Molecular Medicine, Division of Medical Virology, University of Cape Town, Cape Town, South Africa.
  • Stamatatos L; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Korber BT; Theoretical Biology and Biophysics, Los Alamos National Laboratory, and the New Mexico Consortium, Los Alamos, New Mexico, USA.
  • Chen B; Division of Molecular Medicine, Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
  • Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA dbarouch@bidmc.harvard.edu.
J Virol ; 89(5): 2507-19, 2015 Mar.
Article en En | MEDLINE | ID: mdl-25540368
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / VIH-1 / Vacunación / Vacunas contra el SIDA / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Anticuerpos Neutralizantes Límite: Animals Idioma: En Revista: J Virol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / VIH-1 / Vacunación / Vacunas contra el SIDA / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Anticuerpos Neutralizantes Límite: Animals Idioma: En Revista: J Virol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos